 |
0 Diseases |  |
79 Trials |
|
79 Trials |  |
6783 News |  |
| «12...75767778798081828384858687» |
- furosemide / Generic mfg., spironolactone / Generic mfg.
Enrollment open: DESALT Study: Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea (clinicaltrials.gov) - Mar 18, 2014
P4, N=54, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
Not yet recruiting --> Recruiting
- |||| furosemide / Generic mfg.
Trial completion: Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure (clinicaltrials.gov) - Feb 22, 2014
P4, N=198, Completed, Sponsor: University of Calgary
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- furosemide / Generic mfg.
Clinical: Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=270, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
- furosemide / Generic mfg.
Enrollment change: AKI: Protocol to Assess the Severity of Acute Kidney Injury (clinicaltrials.gov) - Feb 17, 2014
P=N/A, N=44, Completed, Sponsor: George Washington University
No longer recruiting --> Completed N=150 --> 44
- furosemide / Generic mfg.
Trial completion: AKI: Protocol to Assess the Severity of Acute Kidney Injury (clinicaltrials.gov) - Feb 17, 2014
P=N/A, N=44, Completed, Sponsor: George Washington University
N=150 --> 44 Recruiting --> Completed
- furosemide / Generic mfg., spironolactone / Generic mfg.
Trial withdrawal: A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1) (clinicaltrials.gov) - Feb 16, 2014
P=N/A, N=0, Withdrawn, Sponsor: Yonsei University
Recruiting --> Completed Recruiting --> Withdrawn
- furosemide / Generic mfg., spironolactone / Generic mfg.
Enrollment change: A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1) (clinicaltrials.gov) - Feb 16, 2014
P=N/A, N=0, Withdrawn, Sponsor: Yonsei University
Recruiting --> Withdrawn N=60 --> 0
- | Zurampic (lesinurad) / AstraZeneca
Trial completion: Metformin and Furosemide Drug-Drug Interaction Study (clinicaltrials.gov) - Feb 12, 2014
P1, N=23, Completed, Sponsor: Ardea Biosciences, Inc.
N=60 --> 0 Active, not recruiting --> Completed
- | Trial completion: Action to Control Cardiovascular Risk in Diabetes (ACCORD) (clinicaltrials.gov) - Feb 6, 2014
P3, N=10251, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- furosemide / Generic mfg.
New P3 trial: FADE: Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial (clinicaltrials.gov) - Feb 3, 2014
P3, N=50, Not yet recruiting, Sponsor: Hamilton Health Sciences Corporation
- | Zurampic (lesinurad) / AstraZeneca
New P1 trial: Metformin and Furosemide Drug-Drug Interaction Study (clinicaltrials.gov) - Jan 5, 2014
P1, N=23, Completed, Sponsor: Ardea Biosciences, Inc.
- furosemide / Generic mfg.
Enrollment change: Measurement of Kidney Blood Flow and Oxygen Levels by MRI (clinicaltrials.gov) - Dec 15, 2013
P=N/A, N=10, Completed, Sponsor: Wake Forest School of Medicine
Active, not recruiting --> Completed N=20 --> 10
- furosemide / Generic mfg.
Trial completion: Measurement of Kidney Blood Flow and Oxygen Levels by MRI (clinicaltrials.gov) - Dec 15, 2013
P=N/A, N=10, Completed, Sponsor: Wake Forest School of Medicine
N=20 --> 10 Recruiting --> Completed
- furosemide / Generic mfg.
Trial completion: Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions) (clinicaltrials.gov) - Dec 10, 2013
P1, N=10, Completed, Sponsor: LTS Lohmann Therapie-Systeme AG
Recruiting --> Completed Active, not recruiting --> Completed
- hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
Enrollment open: Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function (clinicaltrials.gov) - Nov 28, 2013
P4, N=36, Recruiting, Sponsor: Corporacion Parc Tauli
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- furosemide / Generic mfg.
Trial initiation date: Inhaled Nebulized Furosemide & Physical Activity-Related Breathlessness (clinicaltrials.gov) - Nov 27, 2013
P0, N=28, Not yet recruiting, Sponsor: McGill University
Not yet recruiting --> Recruiting Initiation date: Jun 2013 --> Sep 2014
- hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
New P4 trial: Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function (clinicaltrials.gov) - Nov 4, 2013
P4, N=36, Recruiting, Sponsor: Corporacion Parc Tauli
- | furosemide / Generic mfg., spironolactone / Generic mfg.
New P4 trial: DESALT Study: Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea (clinicaltrials.gov) - Sep 17, 2013
P4, N=54, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
- furosemide / Generic mfg.
Trial termination: DAD-HF II: Dopamine in Acute Decompensated Heart Failure II (clinicaltrials.gov) - Sep 9, 2013
P4, N=161, Terminated, Sponsor: Larissa University Hospital
Initiation date: Jun 2013 --> Sep 2014 Recruiting --> Terminated; Safety issues in the LDFD-group (higher heart rate with dopamine)
- furosemide / Generic mfg.
Enrollment change: DAD-HF II: Dopamine in Acute Decompensated Heart Failure II (clinicaltrials.gov) - Sep 9, 2013
P4, N=161, Terminated, Sponsor: Larissa University Hospital
Recruiting --> Terminated; Safety issues in the LDFD-group (higher heart rate with dopamine) N=450 --> 161
- | torasemide / Generic mfg.
New P4 trial: TORNADO: The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure (clinicaltrials.gov) - Aug 23, 2013
P4, N=100, Not yet recruiting, Sponsor: Medical University of Warsaw
- furosemide / Generic mfg.
Enrollment change: Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction (clinicaltrials.gov) - Jul 25, 2013
P2, N=11, Terminated, Sponsor: Barnes-Jewish Hospital
N=450 --> 161 N=60 --> 11
- furosemide / Generic mfg.
Enrollment change: Aerosol Inhalation Treatment for Dyspnea (clinicaltrials.gov) - Jul 16, 2013
P1/2, N=24, Recruiting, Sponsor: Beth Israel Deaconess Medical Center
N=60 --> 11 N=12 --> 24
- | furosemide / Generic mfg.
New P4 trial: ROPA-DOP: Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction (clinicaltrials.gov) - Jul 15, 2013
P4, N=120, Recruiting, Sponsor: Johns Hopkins University
- furosemide / Generic mfg.
Trial completion: B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading (clinicaltrials.gov) - Jun 26, 2013
P=N/A, N=50, Completed, Sponsor: Creighton University
N=12 --> 24 Not yet recruiting --> Completed
- || furosemide / Generic mfg., amiloride hydrochloride / Generic mfg.
Trial suspension: Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema (clinicaltrials.gov) - Jun 24, 2013
P3, N=60, Suspended, Sponsor: Eurofarma Laboratorios S.A.
Not yet recruiting --> Completed Not yet recruiting --> Suspended
- furosemide / Generic mfg.
New P1 trial: Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions) (clinicaltrials.gov) - Jun 24, 2013
P1, N=10, Completed, Sponsor: LTS Lohmann Therapie-Systeme AG
- | furosemide / Generic mfg.
Enrollment closed: The Effects of Decreasing the Lasix Dose on the Cardiorenal System (clinicaltrials.gov) - May 7, 2013
P1/2, N=36, Active, not recruiting, Sponsor: Mayo Clinic
Not yet recruiting --> Suspended Enrolling by invitation --> Active, not recruiting
- furosemide / Generic mfg.
Enrollment closed: REWORD-HF REverse WOrsening Renal Function in Decompensated Heart Failure (clinicaltrials.gov) - May 6, 2013
P4, N=186, Active, not recruiting, Sponsor: Niguarda Hospital
Enrolling by invitation --> Active, not recruiting Recruiting --> Active, not recruiting
- torasemide / Generic mfg., furosemide / Generic mfg.
Trial termination: Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure (clinicaltrials.gov) - Apr 23, 2013
P4, N=8, Terminated, Sponsor: Ferrer Internacional S.A.
Recruiting --> Active, not recruiting Recruiting --> Terminated; Slow recruitment
- torasemide / Generic mfg., furosemide / Generic mfg.
Enrollment change: Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure (clinicaltrials.gov) - Apr 23, 2013
P4, N=8, Terminated, Sponsor: Ferrer Internacional S.A.
Recruiting --> Terminated; Slow recruitment N=30 --> 8
- furosemide / Generic mfg.
Trial withdrawal: Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload (clinicaltrials.gov) - Apr 3, 2013
P=N/A, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
N=30 --> 8 Not yet recruiting --> Withdrawn
- furosemide / Generic mfg.
Enrollment change: Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload (clinicaltrials.gov) - Apr 3, 2013
P=N/A, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Withdrawn N=50 --> 0
- furosemide / Generic mfg.
Enrollment change: Furosemide vs Placebo for Brain Relaxation (clinicaltrials.gov) - Apr 1, 2013
P=N/A, N=23, Terminated, Sponsor: Northwestern University
N=50 --> 0 N=400 --> 23
- | furosemide / Generic mfg.
New P4 trial: The Use of Furosemide in Patients on Dialysis (clinicaltrials.gov) - Mar 19, 2013
P4, N=51, Not yet recruiting, Sponsor: St. Michael's Hospital, Toronto
- | furosemide / Generic mfg.
Trial completion: Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis (clinicaltrials.gov) - Feb 10, 2013
P1, N=12, Completed, Sponsor: Sanofi
N=400 --> 23 Active, not recruiting --> Completed
- | ethacrynic acid / Generic mfg., furosemide / Generic mfg.
Trial initiation date, Surgery: Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease (clinicaltrials.gov) - Dec 28, 2012
P3, N=106, Recruiting, Sponsor: Bambino Gesù Hospital and Research Institute
Active, not recruiting --> Completed Initiation date: Jul 2012 --> Oct 2012
- | ethacrynic acid / Generic mfg., furosemide / Generic mfg.
Enrollment open, Surgery: Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease (clinicaltrials.gov) - Dec 28, 2012
P3, N=106, Recruiting, Sponsor: Bambino Gesù Hospital and Research Institute
Initiation date: Jul 2012 --> Oct 2012 Not yet recruiting --> Recruiting
- | Actimab-A (lintuzumab-Ac225) / Actinium
New P1/2 trial: Low Dose Cytarabine and Lintuzumab-Ac225 in Older Patients (clinicaltrials.gov) - Dec 25, 2012
P1/2, N=24, Recruiting, Sponsor: M.D. Anderson Cancer Center
- | furosemide / Generic mfg.
New P1 trial: Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis (clinicaltrials.gov) - Nov 8, 2012
P1, N=12, Completed, Sponsor: Sanofi
- furosemide / Generic mfg.
Trial initiation date: Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload (clinicaltrials.gov) - Nov 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Initiation date: Oct 2012 --> Mar 2013
- furosemide / Generic mfg.
Trial completion: MRS: The Effect of Plasma Osmolality on Brain Glutamate (clinicaltrials.gov) - Aug 22, 2012
P1/2, N=30, Completed, Sponsor: Yale University
Initiation date: Oct 2012 --> Mar 2013 Recruiting --> Completed
- | Tekturna (aliskiren) / PDL
Enrollment change: A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure (clinicaltrials.gov) - Aug 8, 2012
P2, N=37, Completed, Sponsor: Novartis Pharmaceuticals
Recruiting --> Completed N=28 --> 37
- || ethacrynic acid / Generic mfg., furosemide / Generic mfg.
New P3 trial, Surgery: Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease (clinicaltrials.gov) - Jun 25, 2012
P3, N=106, Recruiting, Sponsor: Bambino Gesù Hospital and Research Institute
- furosemide / Generic mfg.
Enrollment open: SHUM: Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis (clinicaltrials.gov) - Jun 25, 2012
P=N/A, N=54, Recruiting, Sponsor: Oregon Health and Science University
N=28 --> 37 Active, not recruiting --> Recruiting
- | Suglat (ipragliflozin) / EMD Serono, Kotobuki, Astellas
New P1 trial: Drug to Drug Interaction Study With Ipragliflozin and Furosemide (clinicaltrials.gov) - Jun 3, 2012
P1, N=24, Completed, Sponsor: Astellas Pharma Europe BV
- | Tekturna (aliskiren) / PDL
Trial completion: A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure (clinicaltrials.gov) - May 2, 2012
P2, N=37, Completed, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Recruiting Recruiting --> Completed
- | Henletor (torsemide) / Orchid
New P1 trial: A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) (clinicaltrials.gov) - Mar 18, 2012
P1, N=26, Not yet recruiting, Sponsor: Merck Sharp & Dohme Corp.
- torasemide / Generic mfg., furosemide / Generic mfg.
New P4 trial: Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure (clinicaltrials.gov) - Mar 7, 2012
P4, N=8, Terminated, Sponsor: Ferrer Internacional S.A.
- | Henletor (torsemide) / Orchid
Enrollment change: The Effects of Glucocorticoids on Mortality and Renal Function in Patients With Acute Decompensated Heart Failure (clinicaltrials.gov) - Feb 16, 2012
P2/3, N=102, Completed, Sponsor: Hebei Medical University
Recruiting --> Completed N=200 --> 102